| Mar'20 | Mar'19 | |||||
|---|---|---|---|---|---|---|
Operating activities: | ||||||
Net loss | ||||||
0 | 0 | |||||
Adjustments required to reconcile net loss to net cash used in operating activities: | ||||||
Financing costs, net | ||||||
0 | 0 | |||||
Depreciation | ||||||
0 | 0 | |||||
Share-based payments | ||||||
0 | 0 | |||||
Write-off of right-of-use related to restructuring | ||||||
0 | 0 | |||||
Changes in operating asset and liabilities : | ||||||
Prepaid and other current | ||||||
0 | 0 | |||||
Other non-current assets | ||||||
0 | 0 | |||||
Trade payables | ||||||
0 | 0 | |||||
Accrued expenses and other | ||||||
0 | 0 | |||||
Net cash used in operating activities | ||||||
0 | 0 | |||||
Investing activities: | ||||||
Purchase of property and equipment | ||||||
0 | 0 | |||||
Net cash used in investing activities | ||||||
0 | 0 | |||||
Financing activities: | ||||||
Proceeds from issuance of ordinary shares and warrants | ||||||
0 | 0 | |||||
Issuance costs | ||||||
0 | 0 | |||||
Net cash provided by financing activities | ||||||
0 | 0 | |||||
Increase (decrease) in cash, cash equivalents and restricted cash | ||||||
0 | 0 | |||||